Analysis of SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction cycle threshold values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence region

by Robert Markewitz, MD, Antje Torge, PhD, Klaus-Peter Wandinger, MD, Daniela Pauli, MD, Justina Dargvainiene, Andre Franke, MD, Luis Bujanda, MD, PhD, José Maria Marimón, PharmD, Jesus M. Banales, PhD, María A. Gutierrez-Stampa, MD, PhD, Beatriz Nafría, BSc, Ralf Junker, MD
Published 2021-09-01